UK offering funding for "stratified medicine" projects
This article was originally published in SRA
Executive Summary
Companies wishing to apply for funding under the collaborative "stratified medicine" initiative being led by the UK Technology Strategy Board should be aware that competitions open on 10 January 2011. The aim is to encourage efforts such as the co-development of drugs and diagnostics that can be used together to better target therapies to specific patient populations1.
You may also be interested in...
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.